申请人:McNeilab, Inc.
公开号:US04742068A1
公开(公告)日:1988-05-03
Dihydropyridine compounds having 1,4,4-trisubstitution of the following formula (I): ##STR1## wherein R is one of --COR.sup.3, R.sup.3 being a group such as phenyl or benzyl; R.sup.4 where R.sup.4 is a heterocycle; --(CH.sub.2).sub.n NR.sup.5 R.sup.6, with R.sup.5 and R.sup.6 being alkyl or joined to define a ring; or --(CH.sub.2).sub.n COOR.sup.7, with R.sup.7 being alkyl or benzyl. R.sup.1 and R.sup.2 are alkyl, phenyl or substituted phenyl. The compounds are useful for the treatment of hypertension in mammals, e.g., in humans.
二氢吡啶化合物具有以下式(I)的1,4,4-三取代物:其中R是--COR^3中的一个,R^3是苯基或苄基等基团;R^4是杂环;--(CH_2)_nNR^5R^6,其中R^5和R^6是烷基或结合以定义环;或--(CH_2)_nCOOR^7,其中R^7是烷基或苄基。R^1和R^2是烷基、苯基或取代苯基。这些化合物对于治疗哺乳动物的高血压,例如人类,是有用的。